TNF and experimental autoimmune encephalomyelitis: Azizi et al. reported that dasatinib exhibited therapeutic effects in a mouse experimental autoimmune encephalomyelitis (EAE) model by decreasing proinflammatory cytokine NO production and TNF-α levels, and Oliveira et al. found that dasatinib inhibits LPS-induced lung inflammation in mice [62, 63].